Clinical Trial Update: SIRONA 2 Trial Heart Failure NYHA Class III [NA]

View source ↗

Summary

This clinical trial update indicates the SIRONA 2 trial for heart failure (NYHA Class III) is currently active but not recruiting, sponsored by Endotronix, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• SIRONA 2

Snippet

Sponsor: Endotronix, Inc. | Conditions: Heart Failure NYHA Class III | NA | Status: ACTIVE_NOT_RECRUITING